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Abstract
Background: Self-assessment of symptoms by patients with chronic conditions is an important element of disease management.
A recent study in a commercially-insured population found that patients who received automated telephone calls for asthma
self-assessment felt they benefitted from the calls. Few studies have evaluated the effectiveness of disease self-assessment in
Medicaid populations. The goals of this study were to: (1) assess the feasibility of asthma self-assessment in a population
predominantly insured by Medicaid, (2) study whether adding a gift card incentive increased completion of the self-assessment
survey, and (3) evaluate how the self-assessment affected processes and outcomes of care.
Methods: We studied adults and children aged 4 years and older who were insured by a Medicaid-focused managed care
organization (MCO) in a pre- and post-intervention study. During the pre-incentive period, patients with computerized
utilization data that met specific criteria for problematic asthma control were mailed the Asthma Control Test (ACT), a self-
assessment survey, and asked to return it to the MCO. During the intervention period, patients were offered a $20 gift card for
returning the completed ACT to the MCO. To evaluate clinical outcomes, we used computerized claims data to assess the
number of hospitalization visits and emergency department visits experienced in the 3 months after receiving the ACT. To
evaluate whether the self-management intervention improved processes of care, we conducted telephone interviews with
patients who returned or did not return the ACT by mail.
Results: During the pre-incentive period, 1183 patients were identified as having problems with asthma control; 25 (2.0%) of
these returned the ACT to the MCO. In contrast, during the incentive period, 1612 patients were identified as having problems
with asthma control and 87 (5.4%) of these returned the ACT to the MCO (p < 0.0001). Of all 95 ACTs that were returned,
87% had a score of 19 or less, which suggested poor asthma control.
During the 3 months after they received the ACT, patients who completed it had similar numbers of outpatient visits, emergency
department visits, and hospitalizations for asthma as patients who did not complete the ACT. We completed interviews with
95 patients, including 28 who had completed the ACT and 67 who had not. Based on an ACT administered at the time of the
interview, patients who had previously returned the ACT to the MCO had asthma control similar to those who had not (mean
scores of 14.2 vs. 14.6, p = 0.70). Patients had similar rates of contacting their providers within the past 2 months whether they
had completed the mailed ACT or not (71% vs. 76%, p = 0.57).
Conclusion: Mailing asthma self-assessment surveys to patients with poorly controlled asthma was not associated with better
asthma-associated outcomes or processes of care in the Medicaid population studied. Adding a gift card incentive did not
meaningfully increase response rates. Asthma disease management programs for Medicaid populations will most likely need to
involve alternative strategies for engaging patients and their providers in managing their conditions.
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Background
Patient self-assessment is a key element of the Chronic
Care Model [1]. Health care systems have successfully
applied this intervention to improve the management of
chronic diseases including diabetes [2-5] and hyperten-
sion [6-9].
Patient self-assessment also holds promise to improve
care for asthma, an important chronic condition that
affects more than 16 million adults and 7 million children
in the United States [10]. Self-assessment has been found
to predict and reduce future hospitalizations and emer-
gency department (ED) visits among patients with asthma
[8,11,12]. In addition, many patients with persistent
asthma do not receive controller medications as recom-
mended by evidence-based guidelines [13]. One impor-
tant reason for underprescribing or underuse of controller
medications may be that patients with asthma sometimes
do not recognize that their asthma is poorly controlled
[14,15]. Patient self-assessment surveys for asthma which
alert patients that their asthma may not be adequately
controlled may prompt patients to visit their asthma pro-
viders or to seek changes in their medication regimens.
The Asthma Control Test (ACT), is a self-assessment sur-
vey that consists of five questions for adults and seven
questions for children ages 4 to 11 years. The ACT is avail-
able at http://www.asthmacontrol.com. The ACT has been
found reliable, valid, responsive, and efficacious in iden-
tifying patients with suboptimal asthma control [16-18].
Although patient self-assessment for asthma has shown
promise in privately insured populations, scant informa-
tion exists about its effectiveness in Medicaid populations.
Medicaid-insured and low-income persons are at higher
risk for poor asthma control [19], and practical interven-
tions that could improve the accuracy of asthma self-
assessment and communication between patients and
health care providers are especially needed.
The goals of this study were to (1) assess the feasibility of
asthma self-assessment in a majority Medicaid popula-
tion, (2) study whether adding a gift card incentive
increased completion of the self-monitoring survey, and
(3) evaluate how this self-assessment affected processes
and outcomes of asthma care. We hypothesized that
asthma self-monitoring in a Medicaid population would
be feasible, that adding a gift card incentive would
increase completion of the self-monitoring survey, and
that self-monitoring would lead to processes of asthma
care that result in fewer hospitalizations and ED visits.
Methods
Study Subjects
This study included adults and children aged 4 years and
older insured by Neighborhood Health Plan (NHP), a
community health center based Medicaid-focused man-
aged care organization (MCO). NHP is contracted with
MassHealth, the state Medicaid agency, to enroll members
eligible for services, and MassHealth approved NHP's par-
ticipation in the study. The study was also approved by the
Human Studies Committee at Harvard Pilgrim Health
Care. At the time of this study, the MCO insured more
than 185,000 persons, including 125,000 who had Med-
icaid. Our study population consisted of patients with evi-
dence of current problematic asthma control based on
claims data. Criteria for inclusion in this population were
developed by the medical director of the MCO with the
goal of identifying patients who were certain to have prob-
lematic asthma control. Criteria included any one of the
following: (1) high use of bronchodilators, defined as
having at least one bronchodilator dispensing in the past
2 weeks and having had 3 or more dispensings of a bron-
chodilator in the past 4 months, (2) high use of systemic
corticosteroids, defined as having at least one dispensing
of a systemic corticosteroid in the past 2 weeks and having
had 3 or more dispensings of a systemic in the past 4
months, or (3) an asthma-related ED visit within the past
6 weeks. As part of routine care, the MCO identified these
patients with problematic asthma control and produced
"asthma trigger reports." All trigger reports were distrib-
uted to the patients' primary care practice sites to alert pro-
viders that certain patients may have poorly controlled
asthma. For a subset of patients, the MCO sent the
patient's trigger report directly to the primary care pro-
vider with the GINA step chart for dose escalation [20].
Study Design
This study used a pre- and post-intervention design to
evaluate the intervention, self-assessment with incentives.
The overall schematic for the study is depicted in Figure 1.
In order to assess processes of care affected by our inter-
vention, we interviewed a small proportion of the popu-
lation studied in order to gain more detailed insight on
the intervention.
Intervention
This study involved two time periods: the pre-incentive
and the incentive periods. During the pre-incentive (self-
assessment without incentives) period, patients meeting
the criteria for problematic asthma control were mailed
the ACT with a cover letter from the MCO suggesting that
it be completed in English or Spanish by each parent or
guardian of each child ages 4 to 11 years or self-completed
by children and adults ages 12 years and older. Responses
used Likert-type rating scales and the sum yielded a score
that suggested a range of control from poor to good. The
cover letter informed the patients or parents that if the
scores were 19 or less, their asthma was in poor control
and they should contact their providers [18,21]. The cover
letter also instructed patients to send the completed self-BMC Public Health 2009, 9:244 http://www.biomedcentral.com/1471-2458/9/244
Page 3 of 9
(page number not for citation purposes)
assessment survey back to the health insurance plan's
asthma case manager, regardless of the score, in a return
envelope with prepaid postage.
Concurrent with our intervention, asthma case managers
at the MCO contacted select patients appearing on the
trigger report. Patients were selected for outreach on the
basis of having appeared on the report at high frequency,
indicative of long-standing problematic asthma control,
based on the clinical expertise of the asthma case manag-
ers. The asthma care management process did not change
between the pre-incentive and incentive periods.
During the incentive period, all patients who were mailed
the asthma self-assessment survey also were offered a $20
gift card to a local supermarket if the patient or parent
returned the completed asthma self-assessment survey to
the MCO.
Claims Data
To evaluate clinical outcomes, we used computerized
claims data to assess the number of hospitalizations and
ED visits experienced in the 3 months after receiving the
ACT. We also used computerized claims data to assess the
number of fills of rescue and controller medications for
asthma. We hypothesized that completion of the ACT
would result in improved processes of care that would
result in fewer hospitalizations and ED visits from
asthma. In addition, we hypothesized that completion of
the ACT would result in fewer numbers of fills of rescue
medications and increased numbers of fills of controller
medications.
Telephone Interviews
We conducted telephone interviews with pre-incentive
and incentive period patients to assess the effectiveness of
the patient self-assessment strategy. For each patient, we
Overall schematic of study Figure 1
Overall schematic of study. During the pre-incentive phase, of 1183 patients with evidence of problematic asthma control 
and were sent mailings containing the ACT, 25 returned the ACT. During the incentive phase, 87 patients out of 1612 patients 
returned the ACT. During the pre-incentive phase, 125 patients were eligible for telephone interviews, and during the incen-
tive phase, 214 patients were eligible. The main reason for ineligibility was lack of an accurate phone number of address. A total 
of 95 telephone interviews were completed.
 
ACT sent to patients 
with problematic asthma 
control 
Pre-incentive phase  Incentive Phase ($20 gift card for returning ACT) 
1183 patients 1612 patients 
Number of patients who 
returned or did not return 
ACT 
25 returned  1158 did not 
return 
87 returned  1525 did not 
return 
Number of patients 
eligible for telephone 
interviews 
7 118      19         195 
Number of patients 
completed telephone 
interviews 
5 30  9 51 
Total interviews 
completed  95 BMC Public Health 2009, 9:244 http://www.biomedcentral.com/1471-2458/9/244
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conducted the follow-up interview within 8 weeks after
the ACT was mailed in order to conduct the interview
while the patients could remember receiving the mailing.
We conducted a second stage screening at the beginning
of each telephone interview and excluded adults who
reported (and children whose parents reported) that they
had never been diagnosed with asthma. The structured tel-
ephone interview was conducted in English or Spanish
and consisted of closed-ended questions. Parents who
participated also received a $20 gift card for completing
the telephone interview, independent of whether they had
returned the ACT to the MCO. We attempted to conduct
telephone interviews with all eligible patients.
During the pre-incentive phase, of 390 patients who were
identified as having high asthma utilization, 262 were
ineligible for our telephone interviews. Reasons for ineli-
gibility were: we did not have an accurate phone number
or address (n = 241); the family did not speak English (n
= 10); the patient denied having asthma during the initial
screen (n = 6); or a family member had previously
enrolled in the study (n = 5). Of the 125 patients who
were eligible for the study during the pre-incentive phase,
35 subjects completed the telephone interviews.
During the incentive phase, of 752 patients who were
identified as having high asthma utilization, 538 were
ineligible. Reasons for ineligibility were: we did not have
an accurate phone number or address (n = 378); the
patient or family member was already enrolled in the
study (n = 113); the patient did not speak English (n =
35); the patient denied having asthma during the inter-
view screen (n = 10), or the patient was unable to com-
plete the survey due to cognitive or physical limitations (n
= 2). Of the 214 patients who were eligible for the study
during the incentive phase, 60 completed telephone inter-
views.
Interview Instrument
The scripted telephone interview lasted approximately 20
minutes. After obtaining informed consent, questions
were asked about baseline demographics including age,
sex, race/ethnicity, highest grade completed in school,
annual family household income, and whether the
patient or parent was employed outside the home. We
also assessed asthma medication use in the previous 12
months and administered the ACT.
In order to assess the processes of care potentially affected
by the intervention, we interviewed a small subsample of
our larger population. We assessed the frequency of
patient contact with their asthma providers in response to
information gleaned from the ACT. For those making con-
tact, we assessed whether it was by telephone, in-person
appointment, or whether the provider directly contacted
the patient, or whether the provider asked the patient to
make an appointment. For patients who had visits with
their providers, we assessed whether the provider commu-
nicated that asthma control needed improvement,
whether the provider recommended alternative or addi-
tional medications, discontinued a medication, or
adjusted dosing of current medications.
In order to assess patient self-efficacy and perceived
asthma control, our telephone interview included five
questions that were adapted by RAND Corporation from
a previous study [22]. We hypothesized that higher
patient self-efficacy and perceived asthma control may be
positively correlated with the likelihood of completing
the ACT. These questions asked patients to report on a 5-
point Likert scale whether their agreement with each state-
ment (with 1 = strongly disagree to 5 = strongly agree)
such as "If I do all the right things, I can successfully man-
age my asthma." We developed a summation score for
self-efficacy and perceived control which ranged from 5
(high self-efficacy and perceived control) to 25 (low self-
efficacy and perceived control).
We chose four questions on patient or parental expecta-
tions for symptoms (or asthma control) from a reliable
and valid 8-item measure developed by Yoos et al [23].
Each question asked the parent to report on a 4-point Lik-
ert scale their agreement with the statement (with 1 =
strongly agreed, 2 = agreed, 3 = disagreed, and 4 = strongly
disagreed). The four questions on expectations for func-
tioning with asthma had high inter-item correlation
(Cronbach's alpha = 0.76) and were combined to form a
summary measure with the possible scores ranging from
4 (lowest expectations) to 16 (highest expectations). We
hypothesized that patients or parents who completed the
ACT may have higher expectations for symptoms and
asthma control. In addition, we hypothesized that among
patients who completed the ACT, patients with higher
expectations may experience the greatest decrease in hos-
pitalizations and ED visits.
For patients who had visits with their asthma providers,
we inquired whether the providers reported that their
asthma control needed improvement, recommended
medication changes, gave or reviewed a written asthma
management plan, or suggested other interventions.
Statistical Methods
We evaluated differences between the pre-incentive and
incentive groups in rates of asthma outpatient visits, hos-
pitalizations, ED visits, controller medications, and rescue
medication using the t-test for continuous variables, Wil-
coxon rank-sum test for non-parametrically distributed
continuous variables or ordinal variables, and chi-squareBMC Public Health 2009, 9:244 http://www.biomedcentral.com/1471-2458/9/244
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test for categorical variables. Analyses were conducted in
R [24].
Results
Incentive Effect and Population Characteristics
During the pre-incentive period, 1183 patients were iden-
tified as having problems with asthma control; 25 (2.0%)
returned the ACT to the MCO. During the incentive
period, 1612 patients were identified and 87 (5.4%)
returned the ACT to the MCO (p < 0.0001). Of all 112
ACTs returned, 87% had a score of 19 or less, consistent
with poor asthma control. We completed telephone inter-
views with a total of 95 patients. Thirteen patients had
returned the ACT to the MCO. In addition, 15 patients
stated during their telephone interviews that they had
completed the ACT but had not mailed it back to the
health plan. Thus, a total of 28 patients had completed the
ACT either based on receipt by the health plan or by self-
report; we compared this group with the 67 patients who
said they had not completed the ACT. In our analysis of
telephone interview data, we grouped patients by whether
they completed vs. did not complete the ACT, instead of
returned vs. did not return the ACT. We felt that even if
patients completed the ACT and forgot to mail the ACT to
the MCO, completion of the ACT could result in changes
in process and outcomes of care. In addition, it was possi-
ble that ACTs of patients could have been lost in the mail.
Table 1 shows demographic and baseline clinical data
from the 95 patients who participated (or whose parents
participated) in telephone interviews. Based on these
data, there were no significant differences between
patients who did vs. did not complete the ACT to the
MCO. Of the patients interviewed, 52% were white, 33%
were black, and 11% were Latino. Seventy percent of fam-
ilies interviewed had a household income of $30,000 or
less. There were also no significant differences for highest
grade completed, household income, or types of medica-
tions used between the patients who completed the ACT
and did not complete the ACT.
For our analyses, we compared patients who completed
the ACT vs. patients who did not complete the ACT. We
combined the patients who completed the ACT in the pre-
and post-incentive phases in order to study our primary
hypothesis that completion of the ACT would result in
changes in processes and outcomes of asthma care. We
Table 1: Demographics of patients who completed the ACT versus did not complete the ACT
N = 95
n (%)
Completed ACT
(n = 28)
Did not complete ACT (n = 67) Total p-value
Employed outside home? 0.11
Yes 8 (29%) 32 (48%) 40 (42%)
No 20 (71%) 35 (52%) 55 (58%)
Race/ethnicity
White 15 (54%) 34 (51%) 49 (52%) 0.18
Black/African-American 8 (28%) 23 (34%) 31 (33%)
Latino 2 (7%) 9 (13.5%) 11 (11%)
Other 3 (11%) 1 (1.5%) 4 (4%)
Highest grade completed
Some high school or less 6 (21%) 12 (18%) 18 (19%) 0.21
High school graduate/some college 20 (72%) 40 (60%) 60 (60%)
Post graduate/college 2 (7%) 15 (22%) 17 (22%)
Household income
$15,000 or less 11 (44%) 24 (37%) 35 (38%) 0.46
$15,000–$30,000 9 (36%) 20 (30%) 29 (32%)
More than $30,000 5 (20%) 22 (33%) 27 (30%)
Using this type of medication in the past 12 months
Beta agonists 26 (38%) 62 (34%) 88 (35%) 0.60
Inhaled corticosteroid 14 (20%) 27 (15%) 41 (16%)
Long acting beta agonists (LABA) 2 (3%) 4 (2%) 6 (2%)
ICS/LABA 12 (17%) 38 (21%) 50 (20%)
Oral corticosteroid 2 (3%) 16 (9%) 18 (7%)
Mast cell stabilizers 9 (13%) 22 (12%) 31 (12%)
Ipratroprium 4 (6%) 10 (5%) 14 (6%)
Theophylline 0 4 (2%) 4 (2%)BMC Public Health 2009, 9:244 http://www.biomedcentral.com/1471-2458/9/244
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hypothesized that adding a monetary incentive would
increase completion of the ACT; however, we expected
that completion of the ACT whether in the pre-incentive
or incentive groups would result in similar changes in
processes and outcomes of asthma care.
Clinical Outcomes Based on Claims Data
Based on claims data analyzed for the 95 patients inter-
viewed, 79% of patients who completed the ACT and 80%
of patients who did not complete the ACT had 1 or more
outpatient visits for asthma in the three months after
receiving the ACT (p = 0.91). There were no differences in
rates of outpatient visit, hospitalizations and ED visits in
the 3 months after mailing ACT between the two groups
(Table 2). Furthermore, patients who completed the ACT
and did not complete the ACT had similar numbers of ED
visits for asthma in the three months after the ACT was
mailed. Similarly, no difference were seen in the number
of prescription fills of beta2-agonists, inhaled corticoster-
oids, long acting beta2-agonists, or leukotriene inhibitors
in the three months after the ACT was mailed. In addition,
no differences were found in any of these outcomes
between patients who were surveyed during the pre-incen-
tive versus the incentive period.
Processes of Care Based on Telephone Interviews
Completion of the ACT did not have an effect on whether
the patient made contact with the provider, how the con-
tact was made, and whether medication changes resulted
from the contact (Table 3). As shown in Table 4, patients
who completed the ACT had a slightly lower level of per-
ceived control than those who did not complete the ACT
(17.9 vs. 18.5, p = 0.23) and those who completed the
ACT had lower expectations of asthma control (11.9 vs
12.6, p = 0.20). When comparing patients who were sur-
veyed during the pre-incentive versus the incentive peri-
ods, no differences were noted for any of the questions on
processes of care.
Discussion
Our study has three key findings. First, mailing asthma
self-assessment surveys to patients with poorly controlled
asthma in a predominantly Medicaid-insured population
showed no evidence of having improved their health care
use and medication use patterns. Secondly, response rates
to the self-assessment surveys were low, and adding a
monetary incentive did not improve response rates in a
way that would justify this intervention. Third, health
plan administrative data can identify patients with current
problematic asthma control.
In this study's population, mailing the ACT to patients
with poorly controlled asthma was not associated with
better outcomes or processes of care. A previous study
found that self-assessment of asthma control with the
Asthma Therapy Assessment Questionnaire (ATAQ)
resulted in reduced numbers of hospitalizations and ED
visits in a large urban medical group practice [11] and
another study found that the findings of the ATAQ was
highly correlated with the ACT score [25]; thus, we
hypothesized that patients who completed the ACT would
have fewer hospitalizations and ED visits as well because
completion of the ACT would make patients aware of and
take actions to rectify their poorly controlled asthma. To
our knowledge, no published studies have demonstrated
whether use of the ACT for asthma self-assessment affects
any patient outcomes. Green and Foels report that they
are studying this outcome but results are not yet available
[26].
Our response rate was very low, most likely because we
were attempting to outreach to a predominantly Medicaid
population. Response rates to mailed surveys in the Med-
Table 2: Outcomes stratified by completed ACT versus did not complete ACT
N(%) Completed ACT Did not complete ACT p-value
Number of outpatient visits for asthma 0.91
0 6 (21%) 13 (20%)
11 2  ( 4 3 % ) 2 7  ( 4 0 % )
2 or more 10 (36%) 27 (40%)
Number of hospitalizations for asthma 0.77
02 5  ( 8 9 % ) 5 7  ( 8 5 % )
1 2 (7%) 5 (7.5%)
2 or more 1 (4%) 5 (7.5%)
Number of ED visits for asthma 0.28
01 9  ( 6 8 % ) 3 8  ( 5 7 % )
1 3 (11%) 17 (25%)
2 or more 6 (21%) 12 (18%)BMC Public Health 2009, 9:244 http://www.biomedcentral.com/1471-2458/9/244
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Table 3: Questions about contact with asthma providers, stratified by whether or not the patients completed the ACT
N = 95
n (%)
Completed ACT (n = 28) Did not complete ACT (n = 67) p-value
In past 2 months, how many times did you make contact with your 
provider?
0 8 (29%) 16 (24%) 0.75
1 11 (39%) 32 (48%)
2+ 9 (32%) 19 (28%)
If contact was made, contact was made by:
Telephone 10 (59%) 25 (56%) 0.48
Appointment to see provider 6 (35%) 14 (32%)
Provider called me 1 (6%) 1 (3%)
Provider asked me to make appt 0 0
Other 0 5 (8%)
Provider felt asthma control needed improvement 12 (67%) 32 (71%) 0.97
Provider recommended another medication 7 (39%) 21 (46%) 0.83
Provider recommended discontinuing a medication 4 (22%) 10 (22%) 0.77
Provider started oral corticosteroid 4 (14%) 17 (25%) 0.36
Provider started inhaled corticosteroid 6 (21%) 17 (25%) 0.88
Provider gave or reviewed written treatment plan 10 (59%) 24 (55%) 0.99
Provider suggested other interventions 4 (22%) 19 (41%) 0.25
Table 4: Self-efficacy, perceived control, expectations for asthma, and attitudes towards providers, stratified by those who completed 
the ACT versus did not complete the ACT.
N = 95
n (%)
Completed ACT
(n = 28)
Did not complete ACT (n = 67) p-value
Mean perceived control score [SD] 17.93 [SD 2.11] 18.58 [SD 3.01] 0.23
Mean expectation score [SD] 11.92 [SD 2.02] 12.56 [SD 2.25] 0.20
How often did you see your asthma provider and not an assistant or partner?
Never/rarely 7 (26%) 19 (29%) 0.37
Sometimes 11 (41%) 17 (26%)
Often/always 9 (33%) 29 (45%)
Not counting your doctor, how many different providers have given you asthma 
care in the past 12 months (mean [SD])
2.18 [SD 2.45] 2.65 [SD 3.86] 0.49
Did any providers call you to check on your asthma without your calling them first?
Yes 11 (39%) 17 (26%) 0.22
No 17 (61%) 49 (74%)BMC Public Health 2009, 9:244 http://www.biomedcentral.com/1471-2458/9/244
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icaid population have been estimated to range 25–35%
[27,28], but our response rates of 2–5.4% were still signif-
icantly lower. One explanation for our low response rate
could be that our survey was targeted towards patients
who had poorly controlled asthma; this sub-population
may be particularly difficult to engage. Over 80% of
patients identified on the asthma trigger report had previ-
ously been identified, and over a third had been identified
>10 times. Such longstanding poor asthma control may
signify or engender tolerance or resignation that requires
more intensive outreach than a mailed survey. The low
response rates may also signify reluctance by patients to
send personal health information to an insurer. Adding
the monetary incentive rate resulted in a higher response
rate of 5.4% compared to 2.0% in the pre-incentive period
(p < 0.0001), but this response rate is too low to warrant
adoption of incentives in practice.
Our approach to identifying patients with poor asthma
control based on computerized utilization data for medi-
cation fills and ED visits appears to be a valid method in
a population of predominantly Medicaid enrollees. Of the
patients who we were able to contact via our telephone
survey, most had ACT scores suggesting poor asthma con-
trol. Thus, using computerized data has good potential to
identify patients with poor asthma control for further
intervention. Higher-intensity interventions, such as
engaging their primary care physicians or case managers
within the patient's practice, may be beneficial.
Despite the strengths of this study, a few caveats deserve
mention. First, the response rate to our survey (28% dur-
ing the pre-incentive and incentive phases) was relatively
low. Nevertheless, we were able to conduct enough inter-
views for our objective of conducting a process evaluation
of the intervention as a way to gain insight of potential
barriers. Our goal was to identify patterns of experience
rather than provide a systematic snapshot of the entire
population. Furthermore, our power to identify an inter-
vention effect on asthma-related health care use was lim-
ited, but no trends were identified. Furthermore, our
utilization outcomes were limited to the three months
after the ACTs were mailed; thus the follow up time period
was relatively brief. Nevertheless, the medication fills were
also similar whether patients completed or did not com-
plete the ACT. We would expect that if completion of the
ACT led to any changes in health care utilization, medica-
tion fills would change within three months of the mail-
ings. As with other surveys, the ACT is prone to recall bias,
however, studies have demonstrated the validity and reli-
ability of this measure [25]. The seasonality of asthma
may affect our results because of our pre-intervention and
intervention design. The pre-incentive period occurred
during July – October while the incentive period was dur-
ing January – April. Nevertheless, similar numbers of
asthma exacerbations and medication fills were noted in
the pre-intervention and intervention periods. Although
our study suggests that that ACT does not influence proc-
esses and outcomes of care, it is possible that our sample
sizes were too small to detect a difference and that with
more completed interviews, we could have detected an
improvement in a process or outcome of care.
Conclusion
Mailing asthma self-assessment surveys to patients with
poorly controlled asthma yielded low completion rates
and showed no evidence of improving asthma health
services use or processes of care. Although health plans
have the ability to reliably identify patients with problem-
atic asthma control, additional interventions are needed
to improve care for low income, multiethnic populations.
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